NorthStar Medical Radioisotopes, LLC - Similar companies

NorthStar Medical Radioisotopes is a commercial-stage nuclear medicine company that develops and produces reliable, environme ... ntally-friendly diagnostic and therapeutic radiopharmaceuticals to address critical patient healthcare needs. Our first FDA-approved product, technetium-99m (Tc-99m), is the most widely used medical radioisotope to assess extent and severity of heart disease and cancer for 40,000 patients in the U.S. daily. Tc-99m is generated using NorthStar’s RadioGenix® System (technetium Tc 99m generator), which uses U.S.-produced, non-uranium based molybdenum-99 (Mo-99) as its source material, reliably supplying our customers. Prior to availability of NorthStar technology, the U.S. solely relied on overseas suppliers for Mo-99, leading to frequent and at times prolonged supply disruptions impacting patient healthcare. The only commercialized U.S. producer of Mo-99 Our company is executing a well-defined plan to expand Mo-99 production capabilities to meet anticipated increased demand for this important medical radioisotope. A robust portfolio NorthStar is also developing commercial-scale production technologies for therapeutic radioisotopes, which are increasingly important options for cancer treatment. We are advancing a portfolio of other radiopharmaceuticals for use in therapeutic and diagnostic applications, to help patients with serious disease. Driving innovation and professional growth NorthStar is invested in game-changing innovation driving the future of radioisotope supply. Working with this advanced technology is challenging yet rewarding for talented individuals who want to be part of an exciting and rapidly growing business. NorthStar’s people drive our solutions, and we are committed to ensuring that we provide fulfilling work experiences and valuable career development opportunities. read more